3,619
Views
25
CrossRef citations to date
0
Altmetric
SPECIAL FOCUS: RNA Vaccines - Editorial

The messenger's great message for vaccination

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jiawu Wan, Jianmei Yang, Zongmei Wang, Ruizhong Shen, Chengguang Zhang, Yuntao Wu, Ming Zhou, Huanchun Chen, Zhen F. Fu, Haiwei Sun, Yinglei Yi, Haifa Shen, Hangwen Li & Ling Zhao. (2023) A single immunization with core–shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs. Emerging Microbes & Infections 12:2.
Read now
Ioannis S. Vizirianakis, Androulla N. Miliotou, George A. Mystridis, Eleftherios G. Andriotis, Ioannis I. Andreadis, Lefkothea C. Papadopoulou & Dimitrios G. Fatouros. (2019) Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeutics. Expert Review of Precision Medicine and Drug Development 4:3, pages 139-151.
Read now
Philipp Reautschnig, Paul Vogel & Thorsten Stafforst. (2017) The notorious R.N.A. in the spotlight - drug or target for the treatment of disease. RNA Biology 14:5, pages 651-668.
Read now

Articles from other publishers (22)

Ryo Okuyama. (2023) mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions. Vaccines 11:12, pages 1737.
Crossref
Androulla N. Miliotou, Sofia K. Georgiou-Siafis, Charikleia Ntenti, Ioannis S. Pappas & Lefkothea C. Papadopoulou. (2023) Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape. Current Issues in Molecular Biology 45:11, pages 9181-9214.
Crossref
Mohammad Chehelgerdi & Matin Chehelgerdi. (2023) The use of RNA-based treatments in the field of cancer immunotherapy. Molecular Cancer 22:1.
Crossref
Vivek P. Chavda, Gargi Jogi, Srusti Dave, Bhoomika M. Patel, Lakshmi Vineela Nalla & Krishna Koradia. (2023) mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!. Vaccines 11:3, pages 507.
Crossref
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 325 530 .
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Luís Alberto Brêda Mascarenhas, Leone Peter Correia da Silva Andrade, Vinícius Pinto Costa Rocha, Milena Botelho Pereira Soares, Peter Berglund, Malcolm S. Duthie, Steven G. Reed & Roberto Badaró. (2021) The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. Vaccines 9:11, pages 1345.
Crossref
Steve Pascolo. (2021) Vaccines against COVID-19: Priority to mRNA-Based Formulations. Cells 10:10, pages 2716.
Crossref
Emanuela Romano, Steve Pascolo & Patrick Ott. (2021) Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients. Journal for ImmunoTherapy of Cancer 9:6, pages e002932.
Crossref
Sara Sousa Rosa, Duarte M.F. Prazeres, Ana M. Azevedo & Marco P.C. Marques. (2021) mRNA vaccines manufacturing: Challenges and bottlenecks. Vaccine 39:16, pages 2190-2200.
Crossref
Ignacio Moya-Ramírez, Clement Bouton, Cleo Kontoravdi & Karen Polizzi. (2020) High resolution biosensor to test the capping level and integrity of mRNAs. Nucleic Acids Research 48:22, pages e129-e129.
Crossref
Hanieh Moradian, Andreas Lendlein & Manfred Gossen. (2020) Strategies for simultaneous and successive delivery of RNA. Journal of Molecular Medicine 98:12, pages 1767-1779.
Crossref
Sezer Okay, Öznur Özge Özcan & Mesut Karahan. (2020) Nanoparticle-based delivery platforms for mRNA vaccine development. AIMS Biophysics 7:4, pages 323-338.
Crossref
Androulla N. Miliotou & Lefkothea C. Papadopoulou. 2020. Chimeric Antigen Receptor T Cells. Chimeric Antigen Receptor T Cells 87 117 .
Anne-Line Coolen, Céline Lacroix, Perrine Mercier-Gouy, Emilie Delaune, Claire Monge, Jean-Yves Exposito & Bernard Verrier. (2019) Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation. Biomaterials 195, pages 23-37.
Crossref
Bregje Leyman, Hanne Huysmans, Séan Mc Cafferty, Francis Combes, Eric Cox, Bert Devriendt & Niek N. Sanders. (2018) Comparison of the Expression Kinetics and Immunostimulatory Activity of Replicating mRNA, Nonreplicating mRNA, and pDNA after Intradermal Electroporation in Pigs. Molecular Pharmaceutics 15:2, pages 377-384.
Crossref
Marc P. Girard & Wayne C. Koff. 2018. Plotkin's Vaccines. Plotkin's Vaccines 400 429.e25 .
B. Pitard & D. Habrant. 2017. Comprehensive Supramolecular Chemistry II. Comprehensive Supramolecular Chemistry II 365 389 .
Thomas Kramps & Knut Elbers. 2017. RNA Vaccines. RNA Vaccines 1 11 .
Jeffrey B Ulmer & Andrew J Geall. (2016) Recent innovations in mRNA vaccines. Current Opinion in Immunology 41, pages 18-22.
Crossref
Margit Schnee, Annette B. Vogel, Daniel Voss, Benjamin Petsch, Patrick Baumhof, Thomas Kramps & Lothar Stitz. (2016) An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs. PLOS Neglected Tropical Diseases 10:6, pages e0004746.
Crossref
Joke Devoldere, Heleen Dewitte, Stefaan C. De Smedt & Katrien Remaut. (2016) Evading innate immunity in nonviral mRNA delivery: don’t shoot the messenger. Drug Discovery Today 21:1, pages 11-25.
Crossref
Jens Geginat, Giulia Nizzoli, Moira Paroni, Stefano Maglie, Paola Larghi, Steve Pascolo & Sergio Abrignani. (2015) Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets. Frontiers in Immunology 6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.